CLINICAL_TRIALS
trial_result
· 2018-01-23
Clinical Trial Update: Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD [Phase 2]
Summary
Phase 2 trial evaluating three doses of PT001 in Japanese subjects with COPD has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23